Objective To investigate and evaluate the efficacy and safety of regional citrate anticoagulation continuous venovenous hemodiafiltration (RCA-CVVHDF) with calcium-containing dialysate and replacement solution. Methods The efficacy and safety of RCA-CVVHDF with calcium-containing dialysate and replacement solution performed in The 940th Hospital of Joint Logistics Support Force of Chinese PLA between Jul 1, 2021 and December 31, 2021 were retrospectively studied. Their CVVHDF operational characteristics, circuit outcomes and new-onset metabolic complications after RCA-CVVHDF with calcium-containing dialysate and replacement solution were analyzed. Results A total of 56 patients, 139 filters and 213 days of CRRT were analyzed. In the 56 patients, 43 were males (76.5%) and 13 were females (23.5%), with the average age of 59.6±20.8 years old (18-99 years old) The median filter life was 35±23h (6～72h), and filter life ≤24h, 25～48h, 49～72h and ≥72h were found in 37.4%, 34.5%, 17.3% and 10.8% respectively of the filters. Mild-to-moderate hypocalcemia and hyponatremia were observed in 18.0 and 5.0 per 100 CRRT days, respectively, but severe hypocalcemia, hyponatremia and any types of hypercalcemia and hypernatremia were not observed. Citrate accumulation was observed in 2.0 per 100 CRRT days, and metabolic acidosis occurred in 8.0 per 100 CRRT days. Conclusions Under close monitoring, RCA-CVVHDF with calcium-containing dialysate and replacement solution can be effective and safe. This method is worth for further clinical practice.
XI Chun-Sheng
,
LIU Tong-Cun
,
CAI Rui-Lian
,
FANG Chun-Tian
,
ZHANG Meng
,
LIU Fei
,
WEI Yu-Shen
,
WANG Jin-Han
. Clinical investigation of regional citrate anticoagulation continuous venovenous hemodiafiltration with calcium-containing dialysate and replacement solution [J]. Chinese Journal of Blood Purification, 2022
, 21(08)
: 576
-579
.
DOI: 10.3969/j.issn.1671-4091.2022.08.008
[1] Ronco C. Evolution of Technology for Continuous Renal Replacement Therapy: Forty Years of Improvements. Contrib Nephrol, 2017, 89（1）：114-123.
[2] Khwaja A. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron Clin Pract, 2012, 120:179-184.
[3] Morabito S, Pistolesi V, Tritapepe L, et al. Using regional citrate anticoagulation for RRTs in critically ill patients with AKI [J]. Clin J Am Soc Nephrol, 2014, 9(12): 2173-2188.
[4] Rhee H, Berenger B, Mehta RL, et al. Regional Citrate Anticoagulation for Continuous Kidney Replacement Therapy With Calcium-Containing Solutions: A Cohort Study. Am J Kidney Dis, 2021,78(4) 550-559.
[5] Ke Bai, Chengjun Liu, Fang Zhou, et al. Regional citrate anticoagulation with a substitute containing calcium for continuous hemofiltration in children. Medicine, 2019, 98(40）:1-5.
[6] Ong SC, Wille KM, Speer R, et al. A continuous venovenous hemofiltration protocol with anticoagulant citrate dextrose formula A and a calcium-containing replacement fluid. Int J Artif Organs, 2014; 37(6):499-502.
[7] 韩锦，王欣，李侠，等. 枸橼酸盐两段式抗凝在含钙置换液连续性肾脏替代治疗中的抗凝效果. 山西医科大学学报，2019，50(12):1750-1754.
[8] 胡霄，何强，李一文，等.枸橼酸抗凝在基于含钙置换液的日间连续性肾脏替代治疗中的应用及护理.浙江医学，2020，42(16):1780-1782.
[9] 郑孝琴，李育霞. 含钙置换液RCA在CRRT中的应用与护理.浙江临床医学,2021, 23(2):286-288.
[10] 席春生, 刘飞, 方春天, 等. 自动局部枸橼酸抗凝连续肾脏替代治疗的临床分析[J]. 中国中西医结合肾病杂志, 2021, 22(2): 150-152.
[11] Kidney Disease: Improving global outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl, 2012; 2:1-138.
[12] Bagshaw SM, Chakravarthi MR, Ricci Z, et al. Precision Continuous Renal Replacement Therapy and Solute Control. Blood Purif, 2016; 42: 238-247.
[13] Murugan R, Hoste E, Mehta RL, et al. Precision Fluid Management in Continuous Renal Replacement Therapy. Blood Purif, 2016; 42: 266-278.
[14] Bianchi NA, Altarelli M, Eckert P, et al. Complications of regional citrate anticoagulation for continuous renal replacement therapy: an observational study. Blood Purif, 2020; 49(5):1-9.
[15] Ricci Z, Romagnoli S. Technical Complications of Continuous Renal Replacement Therapy. Contrib Nephrol, 2018, 194: 99-108.
[16] Shankaranarayanan D, Muthukumar T, Barbar T, et al. Anticoagulation Strategies and Filter Life in COVID-19 Patients Receiving Continuous Renal Replacement Therapy. A Single-Center Experience. Clin J Am Soc Nephrol, 2021, 16(1):124-126.
